Novocure (NVCR.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct30

Novocure released FY2025 9 Months Earnings on October 30 Pre-Market (EST), actual revenue USD 481 M, actual EPS USD -1.0039

13:30

Novocure released FY2025 Q3 earnings on October 30 Pre-Market EST, actual revenue USD 167.2 M (forecast USD 158.94 M), actual EPS USD -0.333 (forecast USD -0.4197)

13:30

Oct23

Novocure to Release FY2025 Q3 Earnings on October 30 Pre-Market EST, Forecast Revenue USD 158.56 M, EPS USD -0.4214

00:12

Oct13

Nierengarten Reiterates NovoCure Hold Rating and Price Target

12:16

Oct7

Analyst Kumar Reiterates Hold Rating on NovoCure

14:13

Jul24

Novocure released FY2025 Semi-Annual earnings on July 24 Pre-Market (EST), actual revenue USD 313.8 M, actual EPS USD -0.6712

13:30

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 167.2 M, Net Income -37.27 M, EPS -0.333

Jul24

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 158.81 M, Net Income -40.14 M, EPS -0.3597

Apr24

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 154.99 M, Net Income -34.32 M, EPS -0.3111

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More